Skip to content

KTTA

Pasithea Therapeutics Corp.

NASDAQ · Healthcare · Biotechnology · US

$0.41
−1.83%
Ask drillr

Margins

Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-42.7%
Return on equity
-41.2%
Return on assets
-48.1%
Return on invested capital
0.00x
Asset turnover
-$17.8M
Cash from operations
$1.37
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026